DNA Microarray Market Size, Share, and Trends 2025 to 2034

The DNA microarray market is projected to grow from USD 2.73 billion in 2025 to over USD 6.13 billion by 2034, driven by a CAGR of 9.43%. Rising prevalence of genetic disorders, increasing demand for personalized medicine, and advancements in genomics research are fueling this growth. North America leads the market, while Asia-Pacific is expected to grow fastest. Innovations in customized microarrays and omics integration are creating new opportunities across clinical and research applications.

Last Updated : June 2025  |  Report Code : 3648  |  Category : Healthcare  |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on DNA Microarray Market 

5.1. COVID-19 Landscape: DNA Microarray Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global DNA Microarray Market, By Type

8.1. DNA Microarray Market, by Type

8.1.1 Complementary DNA Microarrays

8.1.1.1. Market Revenue and Forecast

8.1.2. Oligonucleotide DNA Microarrays

8.1.2.1. Market Revenue and Forecast

8.1.3. Others

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global DNA Microarray Market, By Application

9.1. DNA Microarray Market, by Application

9.1.1. Gene Expression Analysis

9.1.1.1. Market Revenue and Forecast

9.1.2. Genotyping

9.1.2.1. Market Revenue and Forecast

9.1.3. Others

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global DNA Microarray Market, By End-user 

10.1. DNA Microarray Market, by End-user

10.1.1. Pharmaceutical and Biotechnology Companies

10.1.1.1. Market Revenue and Forecast

10.1.2. Diagnostic Centers

10.1.2.1. Market Revenue and Forecast

10.1.3. Hospitals and Clinics

10.1.3.1. Market Revenue and Forecast

10.1.4. Academic and Research Institute

10.1.4.1. Market Revenue and Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global DNA Microarray Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Type

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End-user

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Type

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End-user

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Type

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End-user

11.2. Europe

11.2.1. Market Revenue and Forecast, by Type

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End-user

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Type

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End-user

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Type

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End-user

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Type

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End-user

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Type

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End-user

11.3. APAC

11.3.1. Market Revenue and Forecast, by Type

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End-user

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Type

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End-user

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Type

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End-user

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Type

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End-user

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Type

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End-user

11.4. MEA

11.4.1. Market Revenue and Forecast, by Type

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End-user

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Type

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End-user

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Type

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End-user

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Type

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End-user

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Type

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End-user

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Type

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End-user

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Type

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End-user

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Type

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End-user

Chapter 12. Company Profiles

12.1. Thermo Fisher Scientific Inc.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Agilent Technologies, Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Illumina, Inc.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. PerkinElmer, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Bio-Rad Laboratories, Inc.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Roche Diagnostics

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Qiagen N.V.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Oxford Gene Technology (OGT)

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Applied Microarrays, Inc.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Eurofins Genomics LLC

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global DNA microarray market size is expected to increase USD 6.13 billion by 2034 from USD 2.49 billion in 2024.

The global DNA microarray market will register growth rate of 9.43% between 2025 and 2034.

The major players operating in the DNA microarray market are Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Illumina, Inc., PerkinElmer, Inc., Bio-Rad Laboratories, Inc., Roche Diagnostics, Qiagen N.V., Oxford Gene Technology (OGT), Applied Microarrays, Inc., Eurofins Genomics LLC, LC Sciences, Microarrays Inc., Arrayit Corporation, BioCat GmbH, Savyon Diagnostics Ltd., and Others.

The driving factors of the DNA microarray market are the prevalence of genetic disorders significantly surges and growing demand for biomarker discovery.

North America region will lead the global DNA microarray market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client